Japan to approve Moderna's COVID-19 vaccine as soon as May 21 - Yomiuri
Japanese regulators are set to approve Moderna Inc's COVID-19 vaccine as soon as May 21, the Yomiuri Shimbun newspaper reported Saturday, without citing the source of the information. Takeda Pharmaceutical Co, Japan's biggest drugmaker, is handling domestic regulatory filing and imports of about 50 million doses of the Moderna shot, or enough for 25 million people.
- Country:
- Japan
Japanese regulators are set to approve Moderna Inc's COVID-19 vaccine as soon as May 21, the Yomiuri Shimbun newspaper reported Saturday, without citing the source of the information. Takeda Pharmaceutical Co, Japan's biggest drugmaker, is handling domestic regulatory filing and imports of about 50 million doses of the Moderna shot, or enough for 25 million people. The first doses were flown into Japan from Europe on April 30, ahead of their official approval.
Moderna's would be the second such vaccine to be approved for use in Japan, after the government kicked off its inoculation campaign in the middle of February using Pfizer Inc's shot. Progress has been slow, with less than 2% of Japan's population inoculated so far, the lowest proportion among wealthy countries.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Moderna
- Japan
- Moderna Inc's
- Europe
- Japanese
ALSO READ
Olympics-Surfing-Japan picks Aussie-born O'Connor for bonus Olympics spot
Toyota likely agreed to wage requests as Japan Inc set for big pay bump
Toyota likely agreed to wage requests as Japan Inc set for big pay bump
Japan's Space One Kairos rocket explodes on inaugural flight
Japan's Space One Kairos rocket explodes on inaugural flight